Approach last years advisory board - [ ] Cassie Milmont; Amgen - [ ] Lee Min; Amgen - [ ] Michael Blanks, R/Pharma executive; Beigene - [ ] Ning Leng, R/Pharma organizing committee; Genentech - [ ] Doug Kehlkoff, R Validation Hub Lead; Genentech - [ ] Michael Rimler; GSK - [ ] Andy Nicholls; GSK - [ ] Volha Tryputsen, R/Pharma organizing committee; J&J - [ ] Sumesh Kalappurakal; J&J - [ ] Mark Bynens; J&J - [ ] Harvey Lieberman, R/Pharma executive; Novartis - [ ] Shannon Pileggi; The Prostate Cancer Clinical Trials Consortium (PCCTC) - [ ] Mike Smith; Pfizer - [ ] Max Kuhn; Posit - [ ] Rich Ioannone; Posit - [ ] Paulo Bargo, R/Pharma executive - [ ] James Black, R/Pharma executive; Roche
Approach last years advisory board